These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
342 related items for PubMed ID: 21212693
21. Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsy. Widstam-Attorps U, Berg U, Bohman SO, Lefvert AK. Clin Nephrol; 1992 Nov; 38(5):245-53. PubMed ID: 1451337 [Abstract] [Full Text] [Related]
23. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease. Ekart R, Ferjuc A, Furman B, Gerjevič Š, Bevc S, Hojs R. Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872 [Abstract] [Full Text] [Related]
25. Implication of urinary complement factor H in the progression of immunoglobulin A nephropathy. Liu M, Chen Y, Zhou J, Liu Y, Wang F, Shi S, Zhao Y, Wang S, Liu L, Lv J, Zhang H, Zhao M. PLoS One; 2015 Aug; 10(6):e0126812. PubMed ID: 26035554 [Abstract] [Full Text] [Related]
26. [Study on the predictors for superimposed preeclampsia in patients with IgA nephropathy]. Suetsugu Y, Tokudome G, Sugano N, Yoshizawa T, Endo S, Hara Y, Takane K, Kuriyama S, Hosoya T. Nihon Jinzo Gakkai Shi; 2011 Aug; 53(8):1139-49. PubMed ID: 22351992 [Abstract] [Full Text] [Related]
27. Clinical features and natural history of IgA nephropathy. Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancová E, Stejskalová A, Ritz E. Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260 [Abstract] [Full Text] [Related]
28. Risk stratification of patients with IgA nephropathy. Barbour SJ, Reich HN. Am J Kidney Dis; 2012 Jun; 59(6):865-73. PubMed ID: 22497792 [Abstract] [Full Text] [Related]
30. Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy. Lundberg S, Gunnarsson I, Jacobson SH. Scand J Urol Nephrol; 2012 Apr; 46(2):148-55. PubMed ID: 22214235 [Abstract] [Full Text] [Related]
33. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647 [Abstract] [Full Text] [Related]
34. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model. Liu Y, Zhang Y, Liu D, Tan X, Tang X, Zhang F, Xia M, Chen G, He L, Zhou L, Zhu X, Liu H. Kidney Blood Press Res; 2018 Dec; 43(6):1852-1864. PubMed ID: 30537719 [Abstract] [Full Text] [Related]
37. The MEST score provides earlier risk prediction in lgA nephropathy. Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC, Oxford Derivation, North American Validation and VALIGA Consortia, Oxford Derivation North American Validation and VALIGA Consortia. Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049 [Abstract] [Full Text] [Related]